Advaxis, Inc.
(NASDAQ : ADXS)

( )
ADXS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
GILDGilead Sciences, Inc. 0.45%64.651.0%$562.60m
AMGNAmgen, Inc. 0.08%225.021.3%$478.83m
BIIBBiogen, Inc. 0.37%283.001.4%$397.37m
ILMNIllumina, Inc. 0.12%314.283.5%$327.74m
VRTXVertex Pharmaceuticals, Inc. 0.30%232.661.9%$277.64m
REGNRegeneron Pharmaceuticals, Inc. 2.30%352.002.6%$256.51m
EXASEXACT Sciences Corp. 0.32%91.0024.0%$229.08m
ALXNAlexion Pharmaceuticals, Inc. 0.50%107.502.0%$179.46m
AAgilent Technologies, Inc. 0.72%87.191.6%$136.99m
INCYIncyte Corp. 0.26%76.662.5%$130.00m
SRPTSarepta Therapeutics, Inc. 1.74%119.9814.6%$117.98m
BMRNBioMarin Pharmaceutical, Inc. 0.00%85.894.3%$112.57m
SGENSeattle Genetics, Inc. 2.26%112.936.1%$107.83m
DERMDermira, Inc. 0.48%18.803.8%$86.01m
BLUEbluebird bio, Inc. 1.01%83.9614.2%$84.39m

Company Profile

Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. It has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ.